Cannara Biotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LOVFF research report →
About the company
Cannara Biotech Inc. , together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations.
- CEO
- Zohar Krivorot
- IPO
- 2019
- Employees
- 452
- HQ
- Montréal, QC, CA
Price Chart
- Market Cap
- $123.48M
- P/E
- 17.64
- P/S
- 1.60
- P/B
- 1.47
- EV/EBITDA
- 10.49
- Div Yield
- 0.00%
- Gross Margin
- 32.66%
- Op Margin
- 6.58%
- Net Margin
- 8.97%
- ROE
- 9.40%
- ROIC
- 3.09%
- Revenue
- $107.32M · 31.28%
- Net Income
- $13.08M · 103.09%
- EPS
- $0.14 · 120.13%
- Op Income
- $22.20M
- FCF YoY
- 324.86%
- 52W High
- $1.47
- 52W Low
- $1.10
- 50D MA
- $1.23
- 200D MA
- $1.27
- Beta
- 0.35
- Avg Volume
- 14.48K
Get TickerSpark's AI analysis on LOVFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LOVFF coverage
Recent articles, reports, and earnings notes.
No research on LOVFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LOVFF report →Similar companies
Peers in the same neighborhood.